DeepMed Research

BRISTOL MYERS SQUIBB

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1989-01-01

Employees: 30K

Market Cap: $97.5B

Website: https://www.bms.com/

Clinical Trials

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-04-25

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002207

Locations: 🇺🇸
ID Care Inc, Somerville, New Jersey, United States
🇺🇸
Fanno Creek Clinic, Portland, Oregon, United States
🇺🇸
Dr Iraj Mirshahi, Richmond, Virginia, United States

and more 10 locations

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-04-14

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002176

Locations: 🇺🇸
Univ of California at San Francisco Gen Hosp, San Francisco, California, United States

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-04-14

Lead Sponsor: Bristol-Myers Squibb

Target Recruit Count: 30

Registration Number: NCT00002360

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-04-14

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002177

Locations: 🇺🇸
Univ of California at San Francisco Gen Hosp, San Francisco, California, United States

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

Phase 3

Completed

Conditions: Cachexia
HIV Infections
Anorexia

First Posted Date: 2001-08-31

Last Posted Date: 2007-10-02

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002067

Locations: 🇺🇸
Dr Mark Goldstein, Los Angeles, California, United States
🇺🇸
Eisenhower Med Ctr, Rancho Mirage, California, United States
🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States

and more 11 locations

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Phase 2

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-14

Lead Sponsor: Bristol-Myers Squibb

Target Recruit Count: 25

Registration Number: NCT00002420

Locations: 🇺🇸
Pacific Oaks Med Group, Beverly Hills, California, United States

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Phase 2

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-14

Lead Sponsor: Bristol-Myers Squibb

Target Recruit Count: 25

Registration Number: NCT00002418

Locations: 🇺🇸
Univ of Colorado / Health Science Ctr, Denver, Colorado, United States
🇺🇸
Brown Univ School of Medicine, Providence, Rhode Island, United States
🇺🇸
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

and more 2 locations

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

Not Applicable

Completed

Conditions: HIV Infections
Leukoencephalopathy, Progressive Multifocal

First Posted Date: 2001-08-31

Last Posted Date: 2007-10-02

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002274

Locations: 🇺🇸
Bristol - Myers Squibb Co, Princeton, New Jersey, United States

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Not Applicable

Completed

Conditions: Candidiasis, Oral
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2007-10-02

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002057

Locations: 🇺🇸
Birmingham Veterans Administration Med Ctr / Univ of Alabama, Birmingham, Alabama, United States
🇺🇸
Bristol - Myers Squibb Co, Princeton, New Jersey, United States

A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV

Phase 3

Completed

Conditions: HIV Infections
Chickenpox

First Posted Date: 2001-08-31

Last Posted Date: 2007-10-02

Lead Sponsor: Bristol-Myers Squibb

Registration Number: NCT00002358

Locations: 🇺🇸
Bristol - Myers Squibb Co, Wallingford, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy